Aquestive Therapeutics Inc. (AQST) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Aquestive Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.23
+3.93% today
Market cap
$511M
Overall quality
39/100
Kronos AI 30-day
+1.0%
5 of 8 simulated paths end higher
Aquestive Therapeutics Inc. (AQST) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $511M. It trades at $4.23, up 3.93% today. Its overall quality score is 39 out of 100, ranked against the whole US market. 3 analysts' average target of $8.67 implies +105.0% from today's price. Kronos AI's 30-day forecast is +1.0% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $8.67 |
| Low – high | $6.00 – $10.00 |
| Analysts | 3 |
| Upside to average | +105.0% |
Kronos AI 30-day forecast
| Expected close | $4.11 (+1.0%) |
| Likely range | −3.0% … +5.5% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
| Profitability | 24 |
| Solvency | 45 |
| Growth | 47 |
| Overall | 39 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.